Work-Related and Health Care Cost Burden of Community-Acquired Pneumonia in an Employed Population

Journal of Occupational and Environmental Medicine

Volumn 55, Issue 10, 2013, Pages 1149-1156

  Kleinman, Nathan L ^a   Yu, Holly ^b   Beren, Ian A ^a   Sato, Reiko ^b  

^a Human Capital Management Services   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; CONTROLLED STUDY; DISABILITY; DRUG COST; EMPLOYEE; FEMALE; HEALTH CARE COST; HUMAN; INCIDENCE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL LEAVE; WORKMAN COMPENSATION;

ADOLESCENT; ADULT; COMMUNITY-ACQUIRED INFECTIONS; COMORBIDITY; COST OF ILLNESS; FEMALE; HEALTH CARE COSTS; HUMANS; INCIDENCE; LENGTH OF STAY; MALE; MIDDLE AGED; PNEUMONIA; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SICK LEAVE; UNITED STATES; WORKERS' COMPENSATION; YOUNG ADULT;

EID: 84885643995     PISSN: 10762752     EISSN: 15365948     Source Type: Journal    
DOI: 10.1097/JOM.0b013e3182a7e6af     Document Type: Article

References (27)

1. Brar NK, Niederman MS. Management of community-acquired pneumonia: a review and update. Ther Adv Respir Dis. 2011;5:61-78.
2. File TM Jr, Marrie TJ. Burden of community-acquired pneumonia in North American adults. Postgrad Med. 2010;122:130-141.
3. Jackson ML, Neuzil KM, Thompson WW, et al. The burden of communityacquired pneumonia in seniors: results of a population-based study. Clin Infect Dis. 2004;39:1642-1650.
4. Kaplan V, Angus DC, Griffin MF, et al. Hospitalized community-acquired pneumonia in the elderly: Age-and sex-related patterns of care and outcome in the United States. Am J Respir Crit Care Med. 2002;165:766-772.
5. Niederman MS, McCombs JS, Unger AN, et al. The cost of treating community-acquired pneumonia. Clin Ther. 1998;20:820-837.
6. Thomas CP, Ryan M, Chapman JD, et al. Incidence and cost of pneumonia in Medicare beneficiaries. Chest. 2012;142:973-981.
7. Yu H, Rubin J, Dunning S, et al. Clinical and economic burden of communityacquired pneumonia in the Medicare fee-for-service population. J Am Geriatr Soc. 2012;60:2137-2143.
8. Centers for Disease Control and Prevention. CDC/NCHS National Hospital Discharge Survey, 2010. Available at: http://www.cdc.gov/nchs/data/nhds/ 3firstlisted/2010first3 numberage.pdf. Accessed January 22, 2013.
9. Marston BJ, Plouffe JF, File TM Jr, et al. Incidence of community-acquired pneumonia requiring hospitalization: results of a population-based active surveillance study in Ohio. The Community-Based Pneumonia Incidence Study Group. Arch Intern Med. 1997;157:1709-1718.
10. Bonafede MM, Suaya JA, Wilson KL, et al. Incidence and cost of CAP in a large working-age population. Am J Manag Care. 2012;18:380-387.
11. Birnbaum HG, Morley M, Greenberg PE, et al. Economic burden of pneumonia in an employed population. Arch Intern Med. 2001;161:2725-2731.
12. Birnbaum HG, Morley M, Greenberg PE, Colice GL. Economic burden of respiratory infections in an employed population. Chest. 2002;122: 603-611.
13. Colice GL, Morley MA, Asche C, et al. Treatment costs of communityacquired pneumonia in an employed population. Chest. 2004;125: 2140-2145.
14. Polsky D, Bonafede M, Suaya JA. Comorbidities as a driver of the excess costs of community-acquired pneumonia inU.S. commercially-insuredworking age adults. BMC Health Serv Res. 2012;12:379.
15. Brook RA, Wahlqvist P, Kleinman NL, et al. Cost of gastro-oesophageal reflux disease to the employer: a perspective from the United States. Aliment Pharmacol Ther. 2007;26:889-898.
16. Brook RA, Kleinman NL, Choung RS, et al. Functional dyspepsia impacts absenteeism and direct and indirect costs. Clin Gastroenterol Hepatol. 2010;8:498-503.
17. Brook RA, Kleinman NL, Su J, et al. Absenteeism and productivity among employees being treated for hepatitis C. Am J Manag Care. 2011;17: 657-664.
18. Rohrbacker NJ, Kleinman NL, White SA, et al. The burden of atrial fibrillation and other cardiac arrhythmias in an employed population: associated costs, absences, and objective productivity loss. J Occup Environ Med. 2010;52:383-391.
19. Centers for Disease Control and Prevention. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1997;46(RR-8):1-24. Available at: http://www.cdc.gov/ mmwr/pdf/rr/rr4608.pdf. Accessed January 22, 2013.
20. Centers for Disease Control and Prevention. Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23). MMWR 2010;59:1102-1106. Available at: http://www.cdc.gov/mmwr/pdf/wk/mm5934.pdf. Accessed January 22, 2013.
21. Blough DK, Madden CW, Hornbrook MC. Modeling risk using generalized linear models. J Health Econ. 1999;18:153-171.
22. Charlson ME, Pompei P,AlesKL, et al.Anewmethod of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.
23. Schuring M, Burdorf L, Kunst A, Mackenbach J. The effects of ill health on entering and maintaining paid employment: evidence in European countries. J Epidemiol Community Health. 2007;61:597-604.
24. van den Berg TI, Elders LA, Burdorf A. Influence of health and work on early retirement. J Occup Environ Med. 2010;52:576-583.
25. van den Berg T, Schuring M, Avendano M, et al. The impact of ill health on exit from paid employment in Europe among older workers. Occup Environ Med. 2010;67:845-852.
26. Kornum JB, Thomsen RW, Riis A, et al. Type 2 diabetes and pneumonia outcomes: a population-based cohort study. Diabetes Care. 2007;30:2251-2257.
27. Sogaard OS, Lohse N, Gerstoft J, et al. Hospitalization for pneumonia among individuals with and without HIV infection, 1995-2007: a Danish populationbased, nationwide cohort study. Clin Infect Dis. 2008;47:1345-1353.